High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients.
Fabris M, De Marchi G, Domenis R, Caponnetto F, Guella S, Dal Secco C, Cabas N, De Vita S, Beltrami AP, Curcio F, Quartuccio L.
Fabris M, et al. Among authors: quartuccio l.
J Autoimmun. 2022 May;129:102827. doi: 10.1016/j.jaut.2022.102827. Epub 2022 Apr 11.
J Autoimmun. 2022.
PMID: 35427999
Free PMC article.